SINOMUNE PHARMACEUTICAL

Sinomune Pharmaceutical Co., Ltd. is a company engaged in the research, production, sales, and promotion services of pharmaceuticals and functional skincare products in the dermatology field, as well as pharmaceuticals in the nephrology field. It is committed to providing patients with products of clinical value. The company has been deeply involved in the dermatology field for many years, adhering to the corporate mission of "focusing on specialized fields and doing valuable work," practicing the business philosophy of "Know Origin, Go Far," and striving to build core competitive advantages in the dermatology field. In the nephrology field, it focuses on the research and development and promotion of Tripterygium-based botanical drugs with immunomodulatory effects to address immune-related kidney diseases. The company has developed a series of branded products such as Lofu®, Liv®, Jinnyler®, and Zhirun® for fungal skin infections, acne and rosacea, immune-inflammatory skin conditions, scalp and hair issues, and immune-related kidney diseases. As a high-tech enterprise, the company has established the Jiangsu Enterprise Technology Center and the Jiangsu Engineering Technology Research Center. In 2022, it was recognized as a potential unicorn enterprise in the Su Nan National Independent Innovation Demonstration Zone and was named a national specialized, refined, distinctive, and innovative "little giant" enterprise. The company advocates sustainable development and has obtained certifications for the ISO14001 and ISO45001 environmental safety management systems and the ISO50001 energy management system.